Determinants of Public Health Decision-Making in Japan

Vaccines are one of the greatest triumphs in medicine. They have also, however, been accompanied by an equally long history of vaccine hesitancy. One of the recent instances is the HPV vaccine, probably the most important vaccine against cancer to date. Despite huge successes worldwide, there is a significant anti-vaccine movement, and this has been particularly virulent in Japan, where the government issued a nationwide suspension of its vaccine recommendation. This book explores the political and institutional factors that contributed to this decision, and beyond that, whether this decision to suspend should have been made. To date, no previous study has been conducted on this topic. This book argues that Japanese government officials make immunization-program decisions based on broader institutional features of the state, and not on the value of the vaccine, to the detriment of public health. Government officials face incentives that result in vaccine suspensions when there is ambiguous legal liability, immense political pressure, short executive time horizons, and a risk-averse culture.

Autorentext

Shimin Ooi graduated from Princeton University with a major in the Woodrow Wilson School of Public and International Affairs and a certificate in Finance. She is passionate about health policy and healthcare, and is on a journey to discover the context of global health challenges and the many ways we can meet these needs.